EP2558105
BARDOXÓLÓN (E. BARDOXOLONE) METÝL TIL AÐ MEÐHÖNDLA OFFITU
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.4.2011EP published:
20.11.2019EP application number:
11715645.5
EP translation filed:
6.1.2020Grant published:
15.3.2020EPO information:
European Patent Register
Max expiry date:
11.4.2031Expiry date:
11.4.2026Next due date:
30.4.2026
Title:
BARDOXOLONE METHYL FOR THE TREATMENT OF OBESITY
Timeline
Today
12.4.2011EP application
20.11.2019EP Publication
6.1.2020Translation submitted
15.3.2020Registration published
11.4.2026Expires
Owner
Name:
Reata Pharmaceuticals Holdings, LLCAddress:
5320 Legacy Drive, Plano, Texas 75024, US
Inventor
Name:
MEYER, Colin, J.Address:
Irving, TX, US
Name:
HUFF, WarrenAddress:
Irving, TX, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
389090 PDate:
1.10.2010Country:
US
Number:
323276 PDate:
12.4.2010Country:
US
Classification
Categories:
A61K 31/275, A61P 3/04
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 26.3.2020
Expires: 11.4.2021
Payer: Árnason Faktor ehf.
Number: 11
Paid: 29.3.2021
Expires: 11.4.2022
Payer: Árnason Faktor ehf.
Number: 12
Paid: 23.3.2022
Expires: 11.4.2023
Payer: Árnason Faktor ehf.
Number: 13
Paid: 26.3.2023
Expires: 11.4.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 26.3.2024
Expires: 11.4.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 8.4.2025
Expires: 11.4.2026
Payer: Árnason Faktor ehf.